On June 17, 2023, Nymox Pharmaceutical Corporation terminated the employment of each of Mr. Christopher R. Riley, Chief Financial Officer. The Company has initiated a search for a Chief Financial Officer, and is in the process of hiring a general counsel to assume the role of Mr. Lanham.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 USD | 0.00% | +3.38% | -49.15% |
1st Jan change | Capi. | |
---|---|---|
-49.15% | 28.01M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Termination of Christopher R. Riley as Chief Financial Officer